In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMAR
about
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMAR
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 26 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
In vitro activity of ceftazidi ...... ial Resistance in Taiwan (SMAR
@en
In vitro activity of ceftazidi ...... ial Resistance in Taiwan (SMAR
@nl
type
label
In vitro activity of ceftazidi ...... ial Resistance in Taiwan (SMAR
@en
In vitro activity of ceftazidi ...... ial Resistance in Taiwan (SMAR
@nl
prefLabel
In vitro activity of ceftazidi ...... ial Resistance in Taiwan (SMAR
@en
In vitro activity of ceftazidi ...... ial Resistance in Taiwan (SMAR
@nl
P2093
P2860
P356
P1476
In vitro activity of ceftazidi ...... l Resistance in Taiwan (SMART)
@en
P2093
Fu-Der Wang
Min-Chi Lu
Pei-Lan Shao
Po-Liang Lu
Shio-Shin Jean
Shu-Hui Tseng
Ting-Shu Wu
Wen-Chien Ko
Zhi-Yuan Shi
P2860
P304
P356
10.2147/IDR.S175679
P407
P50
P577
2018-10-01T00:00:00Z